Showing 1511-1520 of 2050 results for "".
- Ultrasound Helps Clinicians Target Filler Complications with Greater Precisionhttps://modernaesthetics.com/news/ultrasound-helps-clinicians-target-filler-complications-with-greater-precision/2484765/Ultrasound imaging may play a critical role in identifying and treating serious vascular complications associated with hyaluronic acid filler injections, according to new research presented at the 2025 Radiological Society of North America (RSNA) annual meeting. Researchers led by Rosa Mar
- Expert Panel Recommends Diversity-Informed Standards for Facial Aesthetic Assessmenthttps://modernaesthetics.com/news/expert-panel-recommends-diversity-informed-standards-for-facial-aesthetic-assessment/2484691/A multidisciplinary panel of dermatologic and aesthetic experts led by American Society for Dermatologic Surgery (ASDS) president Kavita Mariwalla, MD, is calling for a shift away from Western-centric beauty norms toward more culturally inclusive, patient-centric f
- ODAC 2026 Adds Hands-On, High-Impact Workshopshttps://modernaesthetics.com/news/odac-2026-adds-hands-on-high-impact-workshops/2484689/The ODAC Dermatology Conference will return to Orlando, Florida, in 2026 with a refreshed slate of interactive, expert-led sessions that emphasize skill-building across medical, surgical, and aesthetic dermatology, organizers said in a press release. Scheduled for J
- RVL Pharmaceuticals Announces New CEO, Chief Growth Officerhttps://modernaesthetics.com/news/rvl-pharmaceuticals-announces-new-ceo-chief-growth-officer/2484615/RVL Pharmaceuticals, Inc. has appointed Lori Deo as Chief Executive Officer and Amy Shah as Chief Growth Officer, signaling a strategic leadership shift aimed at accelerating growth for its lead product, Upneeq (oxymetazoline hydrochloride ophthalmic solution), 0.1%. Deo, who previously se
- Allergan Aesthetics Celebrates Seventh Annual BOTOX® Cosmetic Dayhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-seventh-annual-botox-cosmetic-day/2484512/Allergan Aesthetics, an AbbVie company, marks the seventh annual BOTOX® Cosmetic Day on Wednesday, November 19, 2025. The yearly celebration honors patients and providers who have contributed to the longevity and success of the injectable treatment, which remains the top-selling product in its ca
- FDA Warns Websites Selling Unapproved Botulinum Toxin Productshttps://modernaesthetics.com/news/fda-warns-websites-selling-unapproved-botulinum-toxin-products/2484341/The US Food and Drug Administration (FDA) has issued 18 warning letters to website operators illegally marketing unapproved and misbranded botulinum toxin products for cosmetic and medical use. The enforcement action follows reports of adverse events, including sym
- InMode Appoints Michael Dennison as President of North Americahttps://modernaesthetics.com/news/inmode-appoints-michael-dennison-as-president-of-north-america/2484275/InMode Ltd has promoted Michael Dennison to president of North America, the company announced. Dennison previously served as vice president of sales. Dennison joined InMode nearly a decade ago and has held multiple leadership r
- Dermal Repair Complex Wins 2025 Nourish Award for Beauty and Collagen Supplementhttps://modernaesthetics.com/news/dermal-repair-complex-wins-2025-nourish-award-for-beauty-and-collagen-supplement/2484256/Beverly Hills MD Dermal Repair Complex has received the 2025 Nourish Award in the Beauty and Collagen category, according to a company announcement. The supplement, developed by cosmetic surgeons John Layke, DO, and Payman Danielpour, MD, is marketed as a skin-focused nutritional product formulat
- FDA Clears AVAVA Device for Wrinkle Treatment Across All Skin Typeshttps://modernaesthetics.com/news/fda-clears-avava-device-for-wrinkle-treatment-across-all-skin-types/2484238/AVAVA® has received US Food and Drug Administration (FDA) clearance for the treatment of fine lines and wrinkles across Fitzpatrick skin types I-VI, marking its second clearance in recent months following its prior approval for acne scars. The nonablative platform, powered by Focal Point T
- Neutrogena Recalls Makeup Wipes Due to Bacterial Contaminationhttps://modernaesthetics.com/news/neutrogena-recalls-makeup-wipes-due-to-bacterial-contamination/2484214/The Food and Drug Administration (FDA) issued a Class II risk level for a line of Neutrogena's makeup-removing facial wipes due to potential bacterial infection, according to a statement from the agency. In a brief message, the FDA reported that an internal investigation by the manufacture